ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Clinical Use of Anabolics and Hormones
Clinical Use of Anabolics and Hormones
SARMs - What does the research say?
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 225065" data-attributes="member: 13851"><p>[URL unfurl="true"]https://www.excelmale.com/forum/forums/testosterone-and-mens-health-articles.32/post-thread[/URL]</p><p>[ATTACH=full]22318[/ATTACH]</p><p><em>Athletes are always looking for a competitive edge and many choose to take the clean approach in doing things the right by Training Hard, Eating Right, and Playing Fair. This is actually what we at the Taylor Hooton Foundation say is ALL ME. But there are those who look for ways to try and cheat the system by using a performance-enhancing substance.<strong> Fairly new to the market is a product called Selective Androgen Receptor Modulators or SARMs, which was first introduced in 1998 as a non-steroidal therapeutic drug. Prohibited for use in all collegiate and professional sports, some athletes feel they may be a safer alternative to steroids. Why are SARMs banned for competition and are they safe to take? Are they a safer alternative to steroids and what does the research say about dosage?</strong> </em></p><p><em></em></p><p><em><strong>In this episode, I will be speaking with Dr. James Dalton who has spent over 20 years researching the effects of SARMs in clinical populations as well as exploring the potential side effects of SARMs, their safety, and whether or not he would recommend SARMs to his 19-year-old son who was asking about their use and safety? </strong></em></p><p><em><strong></strong></em></p><p><em><strong>Dr. Dalton’s Bio James T. Dalton, Ph.D. is Dean and Professor of Pharmaceutical Sciences in the College of Pharmacy at the University of Michigan. </strong> He received his Bachelor of Science in Pharmacy from the University of Cincinnati (1986) and a Doctor of Philosophy in pharmaceutics and pharmaceutical chemistry from Ohio State University (1990). Dean Dalton rose through the faculty ranks in the Department of Pharmaceutical Sciences in the College of Pharmacy at the University of Tennessee (1992-2000) before returning to Ohio State where he served as Professor and Chair in the Division of Pharmaceutics (2000-2007). <strong>He began an entrepreneurial leave of absence from Ohio State in 2005 and finally left OSU in 2007 to devote his full-time effort as Chief Scientific Officer at GTx, Inc. in Memphis, TN (2007-2014) where he oversaw the preclinical and clinical development of selective androgen receptor modulators, which he will be talking about today. </strong> He was recently elected to the National Academy of Medicine and is a Fellow of the American Association for the Advancement of Science (AAAS) and the American Association of Pharmaceutical Scientists (AAPS). <strong>He has co-authored over 300 original abstracts and peer-reviewed scientific manuscripts and is an inventor of over 400 the United States and international patent applications related to selective androgen receptor modulators, selective estrogen receptor alpha, and beta ligands, tubulin antagonists, and receptor tyrosine kinase inhibitors.</strong></em></p></blockquote><p></p>
[QUOTE="madman, post: 225065, member: 13851"] [URL unfurl="true"]https://www.excelmale.com/forum/forums/testosterone-and-mens-health-articles.32/post-thread[/URL] [ATTACH type="full" alt="Screenshot (13571).png"]22318[/ATTACH] [I]Athletes are always looking for a competitive edge and many choose to take the clean approach in doing things the right by Training Hard, Eating Right, and Playing Fair. This is actually what we at the Taylor Hooton Foundation say is ALL ME. But there are those who look for ways to try and cheat the system by using a performance-enhancing substance.[B] Fairly new to the market is a product called Selective Androgen Receptor Modulators or SARMs, which was first introduced in 1998 as a non-steroidal therapeutic drug. Prohibited for use in all collegiate and professional sports, some athletes feel they may be a safer alternative to steroids. Why are SARMs banned for competition and are they safe to take? Are they a safer alternative to steroids and what does the research say about dosage?[/B] [B]In this episode, I will be speaking with Dr. James Dalton who has spent over 20 years researching the effects of SARMs in clinical populations as well as exploring the potential side effects of SARMs, their safety, and whether or not he would recommend SARMs to his 19-year-old son who was asking about their use and safety? Dr. Dalton’s Bio James T. Dalton, Ph.D. is Dean and Professor of Pharmaceutical Sciences in the College of Pharmacy at the University of Michigan. [/B] He received his Bachelor of Science in Pharmacy from the University of Cincinnati (1986) and a Doctor of Philosophy in pharmaceutics and pharmaceutical chemistry from Ohio State University (1990). Dean Dalton rose through the faculty ranks in the Department of Pharmaceutical Sciences in the College of Pharmacy at the University of Tennessee (1992-2000) before returning to Ohio State where he served as Professor and Chair in the Division of Pharmaceutics (2000-2007). [B]He began an entrepreneurial leave of absence from Ohio State in 2005 and finally left OSU in 2007 to devote his full-time effort as Chief Scientific Officer at GTx, Inc. in Memphis, TN (2007-2014) where he oversaw the preclinical and clinical development of selective androgen receptor modulators, which he will be talking about today. [/B] He was recently elected to the National Academy of Medicine and is a Fellow of the American Association for the Advancement of Science (AAAS) and the American Association of Pharmaceutical Scientists (AAPS). [B]He has co-authored over 300 original abstracts and peer-reviewed scientific manuscripts and is an inventor of over 400 the United States and international patent applications related to selective androgen receptor modulators, selective estrogen receptor alpha, and beta ligands, tubulin antagonists, and receptor tyrosine kinase inhibitors.[/B][/I] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
X (Twitter)
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Clinical Use of Anabolics and Hormones
Clinical Use of Anabolics and Hormones
SARMs - What does the research say?
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top